About Paragon Vision Sciences
Paragon Vision Sciences is a company based in Gilbert (United States) founded in 1976 was acquired by The Cooper Companies in December 2017. Paragon Vision Sciences offers products and services including CRT Lenses. Paragon Vision Sciences operates in a competitive market with competitors including Neurolens, SynergEyes, Laclarée, Azalea Vision and PixelOptics, among others.
- Headquarter Gilbert, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paragon Vision Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Bausch Health
& 2 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paragon Vision Sciences
Paragon Vision Sciences offers a comprehensive portfolio of products and services, including CRT Lenses.
Overnight lenses that correct myopia by reshaping the cornea non-surgically.
Funding Insights of Paragon Vision Sciences
Investors in Paragon Vision Sciences
Paragon Vision Sciences has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Bausch Health, The Cooper Companies and Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summit Partners is recognized as a growth equity investment firm.
|
Locked | Locked | Locked | |
|
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Locked | Locked | Locked | |
|
Optical correction devices and women's health products are developed.
|
Locked | Locked | Locked |
Investor details for Paragon Vision Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paragon Vision Sciences
Investment portfolio details for Paragon Vision Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Paragon Vision Sciences
Detailed financials for Paragon Vision Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paragon Vision Sciences Comparisons
Peer comparison for Paragon Vision Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paragon Vision Sciences
Paragon Vision Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neurolens, SynergEyes, Laclarée, Azalea Vision and PixelOptics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of prescription lenses and solution for problems related to Digital Vision Syndrome
|
|
| Locked | Locked | Locked |
Hybrid contact lense manufacturers
|
|
| Locked | Locked | Locked |
Eye-wear solutions for presbyopia correction are developed using liquid refraction.
|
|
| Locked | Locked | Locked |
Developer of technology for people with high light sensitivity and ocular disorders
|
|
| Locked | Locked | Locked |
Online platform providing football betting odds and expert predictions services.
|
Detailed competitors of Paragon Vision Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paragon Vision Sciences
Complete news archive for Paragon Vision Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragon Vision Sciences
Paragon Vision Sciences was founded in 1976 and raised its 1st funding round 19 years after it was founded.
Paragon Vision Sciences is headquartered in Gilbert, United States. It is registered at Gilbert, Arizona, United States.
Joe Sicari is the current CEO of Paragon Vision Sciences.
Founded in 1976 and based in Gilbert, United States, Paragon Vision Sciences operates in the eye care sector. Corneal reshaping products, specialty contact lenses, and oxygen-permeable lens materials are produced for treating conditions like Keratoconus and myopia through corneal refractive therapy. Products are sold worldwide via laboratory partners and distributors, focusing on therapeutic applications in ophthalmology.
Paragon Vision Sciences's top competitors include Azalea Vision, Neurolens and Laclarée.
Paragon Vision Sciences offers CRT Lenses.
Paragon Vision Sciences has 3 investors. Key investors include Bausch Health, The Cooper Companies, and Summit Partners.